News | April 15, 2025
Biocon Biologics secures market entry date for Yesafili in US
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Raichur site is the group’s largest API facility and part of a wider network of seven sites
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
PRX-PLUS has a unique product feature with its deep-impacting formula
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
Subscribe To Our Newsletter & Stay Updated
